rs35871586

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_005502.4(ABCA1):ā€‹c.3159T>Gā€‹(p.Val1053Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00999 in 1,614,208 control chromosomes in the GnomAD database, including 101 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.0073 ( 3 hom., cov: 32)
Exomes š‘“: 0.010 ( 98 hom. )

Consequence

ABCA1
NM_005502.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.148
Variant links:
Genes affected
ABCA1 (HGNC:29): (ATP binding cassette subfamily A member 1) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. With cholesterol as its substrate, this protein functions as a cholesteral efflux pump in the cellular lipid removal pathway. Mutations in both alleles of this gene cause Tangier disease and familial high-density lipoprotein (HDL) deficiency. [provided by RefSeq, Sep 2019]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 9-104819668-A-C is Benign according to our data. Variant chr9-104819668-A-C is described in ClinVar as [Likely_benign]. Clinvar id is 364421.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-104819668-A-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.148 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00735 (1119/152314) while in subpopulation NFE AF= 0.0118 (801/68022). AF 95% confidence interval is 0.0111. There are 3 homozygotes in gnomad4. There are 505 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 3 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ABCA1NM_005502.4 linkc.3159T>G p.Val1053Val synonymous_variant 22/50 ENST00000374736.8 NP_005493.2 O95477B7XCW9B2RUU2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ABCA1ENST00000374736.8 linkc.3159T>G p.Val1053Val synonymous_variant 22/501 NM_005502.4 ENSP00000363868.3 O95477
ABCA1ENST00000678995.1 linkc.3159T>G p.Val1053Val synonymous_variant 22/50 ENSP00000504612.1 A0A7I2V5U0

Frequencies

GnomAD3 genomes
AF:
0.00735
AC:
1119
AN:
152196
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00208
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00510
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00331
Gnomad FIN
AF:
0.0105
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0118
Gnomad OTH
AF:
0.00813
GnomAD3 exomes
AF:
0.00750
AC:
1887
AN:
251452
Hom.:
11
AF XY:
0.00746
AC XY:
1014
AN XY:
135900
show subpopulations
Gnomad AFR exome
AF:
0.00178
Gnomad AMR exome
AF:
0.00367
Gnomad ASJ exome
AF:
0.00179
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00421
Gnomad FIN exome
AF:
0.0115
Gnomad NFE exome
AF:
0.0112
Gnomad OTH exome
AF:
0.00961
GnomAD4 exome
AF:
0.0103
AC:
15012
AN:
1461894
Hom.:
98
Cov.:
33
AF XY:
0.0100
AC XY:
7273
AN XY:
727248
show subpopulations
Gnomad4 AFR exome
AF:
0.00143
Gnomad4 AMR exome
AF:
0.00434
Gnomad4 ASJ exome
AF:
0.00168
Gnomad4 EAS exome
AF:
0.0000756
Gnomad4 SAS exome
AF:
0.00428
Gnomad4 FIN exome
AF:
0.0116
Gnomad4 NFE exome
AF:
0.0118
Gnomad4 OTH exome
AF:
0.00922
GnomAD4 genome
AF:
0.00735
AC:
1119
AN:
152314
Hom.:
3
Cov.:
32
AF XY:
0.00678
AC XY:
505
AN XY:
74484
show subpopulations
Gnomad4 AFR
AF:
0.00207
Gnomad4 AMR
AF:
0.00510
Gnomad4 ASJ
AF:
0.00202
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00331
Gnomad4 FIN
AF:
0.0105
Gnomad4 NFE
AF:
0.0118
Gnomad4 OTH
AF:
0.00804
Alfa
AF:
0.00872
Hom.:
1
Bravo
AF:
0.00648
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.0101
EpiControl
AF:
0.0108

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMay 30, 2016Variant summary: The ABCA1 c.3159T>G (p.Val1053Val) variant involves the alteration of a non-conserved nucleotide, resulting in a synonymous change. 5/5 splice prediction tools predict no significant impact on normal splicing. This variant was found in 918/121410 control chromosomes (including 6 homozygotes) at a frequency of 0.0075612, which is approximately 605 times the estimated maximal expected allele frequency of a pathogenic ABCA1 variant (0.0000125), suggesting this variant is a benign polymorphism. One internal sample carrying this variant also carries another deleterious variant PCSK9 p.Tyr142X further supporting for benign outcome. Taken together, this variant is classified as Benign. -
Likely benign, criteria provided, single submitterclinical testingGeneDxJul 10, 2020- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenAug 01, 2024ABCA1: BP4, BP7, BS1, BS2 -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsSep 10, 2019This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Hypoalphalipoproteinemia, primary, 1 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Tangier disease Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.56
CADD
Benign
6.6
DANN
Benign
0.74

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs35871586; hg19: chr9-107581949; API